Raymond James & Associates’s RXO RXO Stock Holding History

Raymond James & Associates’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.34M	Sell	47,749 -3,471	-7%	-$98K	﹤0.01%	2492
2024 Q2	$1.34M	Sell	51,220 -38,217	-43%	-$795K	﹤0.01%	2422
2024 Q1	$1.96M	Sell	89,437 -2,072	-2%	-$44.4K	﹤0.01%	2172
2023 Q4	$2.13M	Sell	91,509 -5,748	-6%	-$116K	﹤0.01%	2066
2023 Q3	$1.92M	Sell	97,257 -4,828	-5%	-$95.1K	﹤0.01%	2046
2023 Q2	$2.31M	Sell	102,085 -6,802	-6%	-$137K	﹤0.01%	1967
2023 Q1	$2.14M	Sell	108,887 -37,238	-25%	-$715K	﹤0.01%	1994
2022 Q4	$2.51M	Buy	+146,125	New	+$2.59M	﹤0.01%	1849

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Raymond James & Associates's RXO Position: Q3 2024 in Review

Raymond James & Associates reduced its RXO (RXO) stake by 6.8% in Q3 2024, selling an estimated $98K and leaving 47,749 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

Raymond James & Associates first reported a position in RXO in Q4 2022 and has held it in 8 quarters since. The position peaked at $2.51M in Q4 2022. 281 funds tracked by Wall St. Rank hold RXO as of Q3 2024.

Raymond James & Associates held 47,749 shares of RXO worth $1.34M as of Q3 2024.
Raymond James & Associates sold 3,471 RXO shares in Q3 2024, an estimated $98K.
RXO made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2492 holding.
Raymond James & Associates first reported a position in RXO in Q4 2022 and has held it in 8 quarters since.
Raymond James & Associates's RXO position peaked at $2.51M in Q4 2022.
281 funds tracked by Wall St. Rank held RXO as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.